• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《神经内分泌肿瘤治疗国际协作组(NANETS)关于低分化(高级别)肺外神经内分泌癌诊断和治疗的共识指南》。

The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas.

机构信息

Department of Gastrointestinal Oncology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.

出版信息

Pancreas. 2010 Aug;39(6):799-800. doi: 10.1097/MPA.0b013e3181ebb56f.

DOI:10.1097/MPA.0b013e3181ebb56f
PMID:20664477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3100733/
Abstract

Extrapulmonary poorly differentiated neuroendocrine carcinomas can originate in the gastrointestinal tract, bladder, cervix, and prostate. These high-grade malignancies are characterized by aggressive histological features (high mitotic rate, extensive necrosis, and nuclear atypia) and a poor clinical prognosis. They are infrequently associated with secretory hormonal syndromes (such as the carcinoid syndrome) and rarely express somatostatin receptors.Most poorly differentiated neuroendocrine carcinomas are locally advanced or metastatic at presentation. First-line systemic chemotherapy with a platinum agent (cisplatin or carboplatin) and etoposide is recommended for most patients with metastatic-stage disease; however, response durations are often short. Sequential or concurrent chemoradiation is recommended for patients with loco-regional disease. In patients with localized tumors undergoing surgical resection, adjuvant treatment (chemotherapy with or without radiation) is warranted in most cases.

摘要

肺外分化差的神经内分泌癌可起源于胃肠道、膀胱、宫颈和前列腺。这些高级别恶性肿瘤的特征为侵袭性组织学特征(高有丝分裂率、广泛坏死和核异型性)和不良的临床预后。它们很少与分泌性激素综合征相关(如类癌综合征),也很少表达生长抑素受体。大多数分化差的神经内分泌癌在就诊时已为局部晚期或转移。对于大多数转移性疾病患者,建议采用含铂药物(顺铂或卡铂)联合依托泊苷的一线全身化疗;然而,缓解持续时间通常较短。对于局部疾病患者,建议序贯或同期放化疗。对于接受手术切除的局限性肿瘤患者,大多数情况下需要辅助治疗(化疗加或不加放疗)。

相似文献

1
The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas.《神经内分泌肿瘤治疗国际协作组(NANETS)关于低分化(高级别)肺外神经内分泌癌诊断和治疗的共识指南》。
Pancreas. 2010 Aug;39(6):799-800. doi: 10.1097/MPA.0b013e3181ebb56f.
2
Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas.目前对低分化胃肠道神经内分泌癌的诊断和治疗的概念。
Endokrynol Pol. 2013;64(1):60-72.
3
The management of extrapulmonary poorly differentiated (high-grade) neuroendocrine carcinomas.肺外低分化(高级别)神经内分泌癌的治疗管理。
Semin Oncol. 2013 Feb;40(1):100-8. doi: 10.1053/j.seminoncol.2012.11.011.
4
Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis.铂类/依托泊苷方案治疗晚期低分化肺神经内分泌癌的疗效:回顾性分析。
Front Endocrinol (Lausanne). 2023 Jan 30;14:1065599. doi: 10.3389/fendo.2023.1065599. eCollection 2023.
5
[Therapeutic management of poorly differentiated neuroendocrine lung tumors and neuroendocrine carcinomas of the digestive system].[低分化神经内分泌性肺肿瘤及消化系统神经内分泌癌的治疗管理]
Bull Cancer. 2016 Oct;103(10):880-895. doi: 10.1016/j.bulcan.2016.06.006. Epub 2016 Aug 6.
6
Unusual Sites of High-Grade Neuroendocrine Carcinomas: A Case Series and Review of the Literature.高级别神经内分泌癌的罕见部位:病例系列及文献综述
Am J Case Rep. 2018 Jun 19;19:710-723. doi: 10.12659/AJCR.908953.
7
Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology.胰腺神经内分泌癌(世界卫生组织G3)的管理:增殖与形态之间的个体化方法。
World J Gastroenterol. 2016 Dec 7;22(45):9944-9953. doi: 10.3748/wjg.v22.i45.9944.
8
Expert consensus: Profiling and management of advanced or metastatic epithelial ovarian cancer.专家共识:晚期或转移性上皮性卵巢癌的评估和管理。
Rev Colomb Obstet Ginecol. 2024 Jun 14;75(1):4094. doi: 10.18597/rcog.4094.
9
Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.肺高分化和中分化神经内分泌肿瘤的诊断与管理进展
Chest. 2017 May;151(5):1141-1146. doi: 10.1016/j.chest.2016.06.018. Epub 2016 Jun 29.
10
Cisplatin-Based versus Carboplatin-Based Chemotherapy for Extrapulmonary Neuroendocrine Carcinomas: A Real-World Study.顺铂为基础与卡铂为基础的化疗治疗肺外神经内分泌癌:一项真实世界研究。
Neuroendocrinology. 2022;112(8):777-783. doi: 10.1159/000520193. Epub 2021 Oct 14.

引用本文的文献

1
A Case of Gastric Neuroendocrine Carcinoma with Disseminated Recurrence 14 Years after Initial Surgery.一例初次手术后14年发生播散性复发的胃神经内分泌癌病例
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.25-0285. Epub 2025 Aug 19.
2
Neuroendocrine carcinoma of esophagus: systematic review and meta-analysis of case series.食管神经内分泌癌:病例系列的系统评价与荟萃分析
BMC Gastroenterol. 2025 Jul 1;25(1):462. doi: 10.1186/s12876-025-04078-5.
3
Poorly Differentiated Neuroendocrine Tumors of the Pancreas: A Comparative Analysis of Primary Versus Secondary Tumors-A Literature Review.胰腺低分化神经内分泌肿瘤:原发性与继发性肿瘤的比较分析——文献综述
Biomedicines. 2025 Jun 11;13(6):1437. doi: 10.3390/biomedicines13061437.
4
Clinicopathological Characteristics of Extrapulmonary Neuroendocrine Carcinomas: Treatment Responses and Survival Outcomes: Single-Center Experience.肺外神经内分泌癌的临床病理特征:治疗反应与生存结果:单中心经验
J Clin Med. 2025 Mar 26;14(7):2264. doi: 10.3390/jcm14072264.
5
Successful Conversion Surgery for Locally Advanced Pancreatic Neuroendocrine Carcinoma: A Case Report.局部晚期胰腺神经内分泌癌的成功转化手术:病例报告
Surg Case Rep. 2025;11(1). doi: 10.70352/scrj.cr.24-0064. Epub 2025 Mar 20.
6
Evaluation of the details and importance of lymphatic, microvascular, and perineural invasion in patients with non-functioning pancreatic neuroendocrine neoplasms based on tumor size and the 2022 World Health Organization classification: a 23-year retrospective analysis.基于肿瘤大小和2022年世界卫生组织分类对无功能性胰腺神经内分泌肿瘤患者的淋巴管、微血管和神经周围侵犯的细节及重要性进行评估:一项23年的回顾性分析
World J Surg Oncol. 2025 Mar 8;23(1):79. doi: 10.1186/s12957-025-03734-0.
7
Incidence and Prognostic Implications of Lymphovascular Invasion in Node-Negative Pancreatic Neuroendocrine Tumors: Results From the US Neuroendocrine Study Group.淋巴结阴性胰腺神经内分泌肿瘤中淋巴管侵犯的发生率及预后意义:美国神经内分泌研究组的结果
J Surg Oncol. 2025 Mar;131(3):465-472. doi: 10.1002/jso.27914. Epub 2024 Oct 13.
8
Successful outcome achieved with adjuvant chemotherapy with irinotecan plus cisplatin in rectal neuroendocrine carcinoma: a case report.伊立替康联合顺铂辅助化疗成功治疗直肠神经内分泌癌:一例报告
Surg Case Rep. 2024 Sep 19;10(1):220. doi: 10.1186/s40792-024-02010-9.
9
Primary coexisting adenocarcinoma of the colon and neuroendocrine tumor of the duodenum: A case report and review of the literature.原发性结肠腺癌合并十二指肠神经内分泌肿瘤:一例病例报告及文献复习
World J Gastrointest Surg. 2024 Aug 27;16(8):2724-2734. doi: 10.4240/wjgs.v16.i8.2724.
10
Case report: Comprehensive follow-up of a Colombian family carrying a novel MEN1 variant linked to a rare ACTH-producing pancreatic neuroendocrine carcinoma.病例报告:对携带一种新型 MEN1 变异体的哥伦比亚家族进行全面随访,该变异体与一种罕见的 ACTH 产生的胰腺神经内分泌癌相关。
Front Endocrinol (Lausanne). 2024 Jul 22;15:1398436. doi: 10.3389/fendo.2024.1398436. eCollection 2024.

本文引用的文献

1
Correlation between grade and prognosis in metastatic gastroenteropancreatic neuroendocrine tumors.转移性胃肠胰神经内分泌肿瘤分级与预后的相关性
Hum Pathol. 2009 Sep;40(9):1262-8. doi: 10.1016/j.humpath.2009.01.010. Epub 2009 Apr 14.
2
Clinical and therapeutic aspects of extrapulmonary small cell carcinoma.肺外小细胞癌的临床与治疗方面
Cancer Treat Rev. 2009 May;35(3):228-36. doi: 10.1016/j.ctrv.2008.10.007. Epub 2008 Dec 9.
3
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.“类癌”百年之后:美国35825例神经内分泌肿瘤的流行病学及预后因素
J Clin Oncol. 2008 Jun 20;26(18):3063-72. doi: 10.1200/JCO.2007.15.4377.
4
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?胃肠道管状非小细胞型高级别神经内分泌癌是一种独特的疾病实体吗?
Am J Surg Pathol. 2008 May;32(5):719-31. doi: 10.1097/PAS.0b013e318159371c.
5
Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center study.肺外小细胞癌与小细胞肺癌的比较:一项回顾性单中心研究
Cancer. 2007 Sep 1;110(5):1068-76. doi: 10.1002/cncr.22887.
6
Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer.一项III期试验,比较单纯支持性治疗与支持性治疗联合口服拓扑替康用于复发小细胞肺癌患者的疗效。
J Clin Oncol. 2006 Dec 1;24(34):5441-7. doi: 10.1200/JCO.2006.06.5821.
7
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.一项随机III期试验,比较伊立替康/顺铂与依托泊苷/顺铂用于先前未治疗的广泛期小细胞肺癌患者的疗效。
J Clin Oncol. 2006 May 1;24(13):2038-43. doi: 10.1200/JCO.2005.04.8595.
8
Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases.胃肠道小细胞癌:64例回顾性研究
Br J Cancer. 2004 May 4;90(9):1720-6. doi: 10.1038/sj.bjc.6601758.
9
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.顺铂和依托泊苷联合同期与序贯胸部放疗治疗局限期小细胞肺癌的Ⅲ期研究:日本临床肿瘤学组研究9104的结果
J Clin Oncol. 2002 Jul 15;20(14):3054-60. doi: 10.1200/JCO.2002.12.071.
10
Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis.小细胞肺癌的预防性颅脑照射:一项文献系统综述及荟萃分析
BMC Cancer. 2001;1:5. doi: 10.1186/1471-2407-1-5. Epub 2001 Jun 19.